DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Osborne K, Neven P, Dirix L. et al
Randomized phase II study of gefitinib (IRESSA) or placebo in combination with tamoxifen in patients with hormone receptor positive metastatic breast cancer [abstract].
Breast Cancer Res Treat 2007; 106 (Suppl. 1): 2067-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.